高级别宫颈鳞状上皮内病变治疗后病灶残留、复发及妊娠  

Residual, Recurrence and Pregnancy of Lesions after Treatment of High-Grade High-Grade Cervical Squamous Intraepithelial Lesions

作　　者：孙培松[1] 程香红 王甜 胡元晶[1] SUN Pei-song;CHENG Xiang-hong;WANG Tian;HU Yuan-jing(Tianjin Central Hospital of Gynecology Obstetrics,Tianjin 300100,China)

机构地区：[1]天津市中心妇产科医院

出　　处：《国际妇产科学杂志》2019年第5期576-579,共4页Journal of International Obstetrics and Gynecology

摘　　要：高级别宫颈鳞状上皮内病变(HSIL)是宫颈癌前病变。约17%未接受治疗的HSIL 可进展为浸润癌。因此,准确规范地处理宫颈病变,特别是HSIL,是预防宫颈癌的重要手段。美国阴道镜和宫颈病理学会(ASCCP)推荐冷刀锥切术(CKC)和宫颈环形电切除术(LEEP)为主要诊疗手段。然而部分患者接受治疗后仍存在病灶残留、病灶复发及进展的风险。目前各研究报道HSIL 治疗后发生病灶残留、复发及进展的差异较大,且术后病灶残留、复发的危险因素、术后随访方式尚无定论。综述HSIL 治疗后病灶残留及复发危险因素、处理、随访及妊娠相关问题,指导临床治疗。High-grade cervical squamous intraepithelial lesion (HSIL) is internationally recognized as precancerous lesions of the cervix. About 17% of untreated HSIL patients are likely to develop into a invasive cancer. Therefore, accurate and standard treatment of cervical lesions, especially HSIL, is an important means to prevent cervical cancer. The American Society of Colposcopy and Cervical Pathology (ASCCP) recommends cold knife conization (CKC) and loop electrosurgical excision procedure (LEEP) as the primary methods of diagnosis and treatment. However, some patients still have the risk of residual lesions, recurrence and progression after treatment. At present, there are great differences in residual lesions, recurrence and progression after HSIL treatment, and the risk factors of residual lesions, recurrence and the mode of follow -up after HSIL treatment are still uncertain. The purpose of this article is to review the risk factors, management, follow-up and pregnancyrelated issues of residual and recurrent lesions after HSIL treatment, so as to guide clinical treatment.

关 键 词：宫颈鳞状上皮内病变 切缘阳性 病灶残留 复发 锥切后妊娠 

分 类 号：R737.33[医药卫生—肿瘤]